Evidence map›Paper›PMID 40009328›Full record

ReviewDiscover oncology2025

Exploring the role of oral bacteria in oral cancer: a narrative review.

Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Parnian Pour Bahrami, Anis Elhami, Farbod Faghihinia, Seyedeh Tabasom Nejati, Kimia Sadat Kazemi, Mohsen Nabi Afjadi

Abstract readReview
In one paragraph

Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. The role ofFrontiers in oral health · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. The Role ofCancers · 2025
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hassan MivehchiFaculty of Dentistry, University of Debrecen, Debrecen, Hungary.
Aisan Eskandari-YaghbastloSchool of Dentistry, Loma Linda University, Loma Linda, USA.
Parnian Pour BahramiFaculty of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
Anis ElhamiFaculty of Dentistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Farbod FaghihiniaSchool of Dentistry, Yasuj University of Medical Sciences, Yasuj, Iran.
Seyedeh Tabasom NejatiSchool of Dentistry, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Kimia Sadat KazemiFaculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran. kazemi.kimia@yahoo.com.
Mohsen Nabi AfjadiDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. mohsen.nabiafjadi@modares.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A growing body of research indicates that a wide range of cancer types may correlate with human microbiome components. On the other hand, little is known about the potential contribution of the oral microbiota to oral cancer. However, some oral microbiome components can stimulate different tumorigenic processes associated with the development of cancer. In this line, two prevalent oral infections, Porphyromonas gingivalis, and Fusobacterium nucleatum can increase tumor growth. The microbiome can impact the course of the illness through direct interactions with the human body and major modifications to the toxicity and responsiveness to different kinds of cancer therapy. Recent research has demonstrated a relationship between specific phylogenetic groupings and the results of immunotherapy treatment for particular tumor types. Conversely, there has been a recent upsurge in interest in the possibility of using microbes to treat cancer. At the moment, some species, such as Salmonella typhimurium and Clostridium spp., are being explored as possible cancer treatment vectors. Thus, understanding these microbial interactions highlights the importance of maintaining a healthy oral microbiome in preventing oral cancers. From this perspective, this review will discuss the role of the microbiome on oral cancers and their possible application in oral cancer treatment/improvement.

Indexed as

; Clostridium sppFusobacterium nucleatumOral cancerOral MicrobiomePorphyromonas gingivalis

Identifiers

PMID40009328
PMCPMC11865422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.